Shares of Rewalk Robotics Ltd (NASDAQ:RWLK) have earned an average rating of “Buy” from the six research firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $3.10.
Several research firms recently commented on RWLK. Piper Jaffray Companies reiterated a “buy” rating and issued a $3.00 price target on shares of Rewalk Robotics in a research report on Sunday. Canaccord Genuity reiterated a “buy” rating and issued a $3.00 price target on shares of Rewalk Robotics in a research report on Monday, November 6th. Zacks Investment Research downgraded shares of Rewalk Robotics from a “buy” rating to a “hold” rating in a research report on Thursday. Oppenheimer set a $3.00 price target on shares of Rewalk Robotics and gave the company a “buy” rating in a research report on Tuesday, December 26th. Finally, Jefferies Group reduced their price target on shares of Rewalk Robotics from $8.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, November 3rd.
Shares of Rewalk Robotics (NASDAQ:RWLK) traded down $0.02 during trading hours on Monday, hitting $1.13. 156,200 shares of the stock traded hands, compared to its average volume of 234,875. The stock has a market cap of $31.82, a P/E ratio of -0.71 and a beta of 0.79. The company has a quick ratio of 1.65, a current ratio of 2.02 and a debt-to-equity ratio of 7.46. Rewalk Robotics has a twelve month low of $1.05 and a twelve month high of $3.60.
A hedge fund recently raised its stake in Rewalk Robotics stock. Advisor Group Inc. raised its position in Rewalk Robotics Ltd (NASDAQ:RWLK) by 1,495.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 181,900 shares of the medical device company’s stock after purchasing an additional 170,500 shares during the period. Advisor Group Inc. owned about 0.82% of Rewalk Robotics worth $264,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 3.23% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Rewalk Robotics Ltd (RWLK) Given Consensus Recommendation of “Buy” by Brokerages” was posted by BBNS and is the sole property of of BBNS. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://baseballnewssource.com/markets/rewalk-robotics-ltd-rwlk-given-consensus-recommendation-of-buy-by-brokerages/1818912.html.
Rewalk Robotics Company Profile
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.